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We have developed a new method for determining the DNA-binding specificity of proteins. In DIP-chip (DNA
immunoprecipitation with microarray detection), protein·DNA complexes are isolated from an in vitro mixture of
purified protein and naked genomic DNA. Whole-genome DNA microarrays are used to identify the protein-bound
DNA fragments, and the sequence of the identified fragments is used to derive binding-site descriptions. Using
objective criteria for assessing the accuracy of DNA-binding motifs, and using yeast Leu3p as a model, we demon-
strate that motifs determined by DIP-chip are as effective at predicting the location of bound proteins in vivo as are
motifs determined by conventional low-throughput in vitro methods.
[Raw data, array images, and compiled tabular data are publicly available as Supplemental material online at www.
genome.org and from the UNC Microarray database at https://genome.unc.edu.]
Accurate binding-site descriptions of hundreds, or perhaps thou-
sands of transcription factors and transcription-factor complexes
will likely be needed to understand how regulatory factors inter-
act with the genome to generate coordinated transcriptional pro-
grams. Well-established methods, like binding-site selection
(SELEX) (Oliphant et al. 1989; Tuerk and Gold 1990) and elec-
trophoretic mobility shift assays (EMSA) (Fried and Crothers
1981) can be used to determine binding specificity, but they are
labor intensive, not amenable to high-throughput analysis, and
do not sample the full range of a protein’s natural in vivo DNA
substrates. An emerging alternative is to isolate and identify se-
quences bound in vivo using ChIP-chip experiments, and to infer
binding motifs from computational analysis of the ChIP-enriched
sequences (Liu et al. 2002). While ChIP-chip is a powerful method,
the ability to infer relevant and accurate binding sites is depen-
dent on adequate expression of the protein of interest. Further-
more, the discovery of binding sites from ChIP-chip data is com-
plicated by the effects of protein–protein interactions, and the
cooperative and competitive DNA binding of other proteins in
vivo. DIP-chip, while similar in concept to ChIP-chip, can over-
come these limitations by inferring accurate DNA-binding speci-
ficities under well-defined and easily varied in vitro conditions.
To compare DIP-chip with established methods for deter-
mining DNA-binding specificity, we also introduce a generally
applicable procedure for evaluating and comparing the quality of
DNA-binding motifs. Unlike conventional metrics for comparing
motifs that are based directly on the motifs themselves (for ex-
ample, the number of matches to a consensus site or the “dis-
tance” between position weight matrices), our procedure is based
on how well each motif predicts the results of an actual binding
experiment. We use this functional metric to define a set of re-
lated motifs obtained from DIP-chip analysis of yeast Leu3p and
show that motifs defined by DIP-chip are able to predict Leu3p
binding in vivo as well as motifs defined by SELEX and EMSA
analysis.
Results
Isolation and identification of protein-bound
DNA using the DIP-chip approach
We developed and tested the DIP-chip methodology using the
DNA-binding domain of the yeast transcription factor Leu3p.
Leu3p was chosen for study because its DNA-binding specificity
had been determined previously by EMSA of 50 binding-site vari-
ants and by SELEX (Liu and Clarke 2002). Here, the same protein
used in those studies, a maltose-binding protein (MBP)-tagged
Leu3 DNA-binding domain, was used in DIP-chip assays to allow
direct comparison to EMSA and SELEX.
The DIP-chip approach is outlined in Figure 1. Leu3p-MBP
protein was mixed with purified yeast genomic DNA (2 µg/mL,
0.3 pM Genome) that had been mechanically sheared to an av-
erage size of 600 bp. Two different concentrations of protein, 4
and 40 nM, were tested. After incubation, Leu3p–DNA complexes
were enriched by affinity purification on amylose resin. The pro-
tein–DNA complexes were then eluted from the resin with malt-
ose. Unlike ChIP, no treatment with formaldehyde or other
cross-linking agent is necessary.
To assess the relative abundance of genomic fragments se-
lected by the purification, retained DNA was purified, amplified,
and labeled fluorescently. In parallel, total genomic DNA was
prepared, amplified, and labeled with a different fluorescent
marker (Lieb et al. 2001). The two samples were then analyzed by
comparative hybridization to DNA microarrays that cover the
entire yeast genome at an average resolution of ∼1 kb (Lieb et al.
2001). DIP experiments were repeated independently at least
three times at each concentration. The significance of enrich-
ment for each feature on the array, expressed as a p-value, was
estimated using a modified single array error model (Methods)
(Ren et al. 2000).
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The DIP-chip method was validated initially by the strong
enrichment of DNA upstream of genes known to be regulated by
Leu3p in vivo (Kohlhaw 2003). Of seven well-characterized
Leu3p-regulated genes, promoter regions of six were among the
top 30 sequences enriched by binding at 40 nM protein (p-value
for enrichment of each sequence  2e-6). The seventh is bound
more weakly (p-value = 0.01), but still ranks among the top 4%
among all 12,000 array features. The enrichment of these se-
quences provided encouragement for the analyses described be-
low, which demonstrate that DNA-binding motifs relevant to the
location of bound protein in vivo can be determined using ge-
nomic sequences bound in vitro, as detected by the DIP-chip
method.
Systematic determination of DNA-binding
specificity from DIP-chip data
To further validate DIP-chip, we sought to determine the DNA-
binding specificity of Leu3p from the DIP-chip data alone, and
compare it with binding-site descriptions obtained by EMSA
and SELEX. To that end, we devised a systematic and objec-
tive procedure to define position weight matrices (PWMs)
(Stormo and Fields 1998) that maximizes the distinction between
protein-bound and unbound sequences. The procedure consists
of two steps. The first step uses the motif discovery programs
BioProspector and MDScan (Liu et al. 2001, 2002) to define
PWMs in a way that ensures that the number of input sequences
has a minimal effect on the results. The second step evaluates the
discovered motifs using the entire experimental data set.
In the motif discovery step (Fig. 2A), we used fixed numbers
of the most highly enriched DNA sequences identified by DIP-
chip. Specifically, BioProspector and MDScan were run using the
sequences of the top 10, 20, …, 100 arrayed features, as ranked by
enrichment p-value (Methods). For each set of input sequences,
the first PWM reported by each program was recorded, resulting
in a total of 20 motifs for each of the two experiments (4 and 40
nM). To simplify comparison to the 10-bp binding sites defined
by SELEX and EMSA Kd, motif searches were restricted to widths
of 10 bp, although searches unrestricted by width find similar
sites (data not shown). Most, but not all of the PWMs identified
by this procedure resemble the Leu3p consensus DNA-binding
site (33/40 have the consensus base as the most favored at each
position).
In the second step of our analysis (Fig. 2B,C), each of the
PWMs found in the first step was evaluated for its ability to dis-
tinguish significantly DIP-enriched features from all other micro-
array features. Significantly DIP-enriched features were defined
using a 1% expected false discovery rate (FDR) (Benjamini and
Hochberg 1995). By this criterion, 23 features were enriched at
4 nM protein (0.23 features expected by chance; enrichment
p-value  1.8e-5) and 60 were enriched at 40 nM protein (0.60
features expected by chance; enrichment p-value  4.6e-5). We
then assessed the ability of each DIP-derived PWM to distinguish
these significantly DIP-enriched sequences from all other se-
quences on the array.
The scoring function and statistical metrics used in evaluat-
ing the binding-site descriptions have been described previously
(Liu and Clarke 2002; Clarke and Granek 2003). Briefly, each
PWM was used to predict the relative Leu3p binding affinity of
all possible binding sites in the genome. We then used these
relative affinities (which are unit-less) to predict the probability
of Leu3p binding at each site. This calculation requires a unit-less
parameter analogous to protein concentration, and we set the
value of this parameter such that the consensus binding site is
predicted to be half-occupied. Having estimated the occupancy
of each binding site, we then determined an “occupancy score”
for each microarray feature by calculating the probability that at
least one site in each feature would be occupied by Leu3p. The
degree to which DIP-enriched features exhibit high Leu3p occu-
pancy scores, compared with nonenriched features, was defined
by the area under a receiver operator characteristic curve (ROC
AUC) (Fig. 2C). The PWM with the highest ROC AUC value in
each experiment was considered the best motif that could be
defined from that experiment (Fig. 3). At both protein concen-
trations, the motifs defined by DIP-chip analysis are similar to
those defined by SELEX and EMSA (Fig. 3).
Many motif descriptions derived from DIP-chip
describe the data equally well
The procedure described above yields the single best motif from
each experiment, but many of the other motifs are similar in
appearance, and indeed, are functionally similar by the objective
criterion of ROC AUC value. We sought to determine whether
Figure 1. The DIP-ChIP method. A purified DNA-binding protein is
incubated with purified, sheared yeast genomic DNA. Protein·DNA com-
plexes are separated from unbound DNA using immunoprecipitation or
affinity purification. Purified DNA fragments are amplified, labeled fluo-
rescently, and identified by hybridization to a DNA microarray. Compu-
tational methods are then used to define a binding site based on enriched
sequences (see text). A detailed description of the DIP-chip experimental




these motifs were significantly worse than the best motifs, or
were really members of a family of motifs that cannot be mean-
ingfully distinguished from one another. This issue arises fre-
quently in the field of motif analysis whenever a variety of bind-
ing-site descriptions are generated by experimental or computa-
tional methods. To resolve this issue, we estimated the 95%
confidence interval for the ROC AUC values of the best motifs
using bootstrap resampling of the occupancy scores and DIP-
enrichment values (Efron and Gong 1983). We found that half of
the 40 discovered motifs fall within the 95% confidence intervals
(four from the 4 nM experiment and 16 from the 40 nM). We
conclude that multiple variants of the motif can explain the DIP-
chip data indistinguishably well. This procedure is generally ap-
plicable, and could be used widely to determine whether motif
representations can be distinguished with confidence. Indeed,
we use the same procedure below to compare DIP-chip-defined
motifs with motifs defined by other methods, but, in this case,
using a completely independent in vivo experimental data set as
our standard for comparison.
DIP-chip predicts in vivo targets as well as EMSA and SELEX
As described above, the DIP-chip experimental protocol, com-
bined with computational procedures for motif discovery, yields
binding sites that resemble superficially those defined by SELEX
or EMSA (Fig. 3). To establish the relative utility of these motifs,
we determined how well each of the PWMs derived from SELEX,
EMSA, or DIP-chip could predict the location of Leu3p binding in
vivo. We performed ChIP-chip experiments to determine the in
vivo binding location of the same epitope-tagged Leu3p frag-
ment used in the DIP-chips. ChIP-chips were repeated indepen-
dently five times, and 22 array features were identified as being
bound in vivo (1% FDR). For each DIP-derived PWM, occupancy
scores were calculated for all arrayed sequences. The scores of the
ChIP-enriched sequences were then compared with those of un-
enriched sequences by ROC analysis (Fig. 4). All Leu3p PWMs
tested, whether defined by classical assays or by DIP-chip, were
found to explain in vivo binding similarly well (Fig. 4B,C). Spe-
cifically, all of the PWMs fall well within the 95% confidence
interval of ROC AUC values for the PWM derived from EMSA Kd
data. The PWMs defined by 40-nM DIP-chip appear to perform
slightly better than both the classically defined PWMs and the
PWMs defined by the 4-nM DIP-chip experiment (Fig. 4C). This
result highlights a key aspect of DIP-chip, which is the ability to
easily control the protein concentration. This allows one to find
Figure 2. Motif discovery procedure. (A) For each of the two protein
concentrations used, array features were ranked according to enrichment
p-value. The sequences corresponding to the top 10, 20, 30, …, 100
features were used as input to BioProspector and MDscan. For each set of
features, indicated by arrows, a single position weight matrix (PWM) was
obtained from each of the two programs. For illustrative purposes, we
show the two motifs discovered using the top 70 features from the 4-nM
experiment (black arrow). This set is interesting because it provides a
contrast between an excellent PWM (MDscan) and a poor one (Biopros-
pector, see B and C). Motifs are represented as sequence logos with the
height of each column representing the information content of that po-
sition in the binding site (Schneider and Stephens 1990). (B) Computa-
tionally defined occupancy scores for the top 75 enriched array features
and for every 200th feature thereafter (4-nM experiment; note the break
in the y-axis and the change in scale). Occupancy scores were calculated
using the two PWMs shown in A (Methods). Filled circles represent the 23
features that meet the 1% false discovery rate criterion for significance; all
other features are shown as open circles. Only the PWM defined by
MDscan (consensus sequence CCGGTACCGG) shows a marked tendency
for the DIP-enriched sequences to have higher occupancy scores than the
nonenriched sequences. (C) A Receiver Operator Characteristic (ROC)
curve (Hanley and McNeil 1982) showing the power of a PWM to dis-
tinguish DIP-enriched sequences from nonenriched. The heavy line with
the shaded area below is for the PWM defined by MDscan in A, while the
light line is for the PWM defined by BioProspector. The curves are equiva-
lent to a plot of the true positives vs. false positives for all possible values
of the occupancy scores that, for a given PWM, would be used to predict
enrichment (see text). Each of the 20 PWMs discovered at each protein
concentration was judged based on the area under the ROC curve (ROC
AUC) obtained using occupancy scores calculated with that PWM. A ROC
AUC value of 0.5, corresponding to a diagonal ROC curve, is expected
by chance, while a value of 1.0 indicates perfect predictive value for
the motif. In this case, the BioProspector-defined motif shows no predic-
tive power (ROC AUC = 0.49), while the MDscan motif does (ROC
AUC = 0.91). Note that the ability of MDscan to outperform Bioprospec-
tor is specific to this example and does not occur in every case.
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the concentration at which the derived in vitro PWM best ex-
plains the in vivo binding distribution.
Discussion
We have developed DIP-chip as a new method for determining
DNA-binding specificity and have demonstrated its utility using
the DNA-binding domain of yeast Leu3p. The method is simple,
and with the widespread availability of microarrays, it should be
possible to quickly determine the in vitro specificity of any epi-
tope-tagged transcription factor. Using genomic DNA and micro-
arrays derived from the same organism as the tested protein fa-
cilitates comparisons to ChIP-chip data (see below) and ensures
that all of the naturally occurring binding sites are present in the
reaction mix. However, the same yeast genomic DNA and yeast
microarrays used here could be used to determine the specificity
of a DNA-binding protein from any organism, not just yeast.
Since, in theory, genomic DNA and microarrays from any organ-
ism could be used to determine the specificity of a protein from
any other organism, a genome sequence with low base-compo-
sition bias and broad representation of all possible binding se-
quences might be best for general use in DIP-chip.
DIP-chip has several advantages over established, nonarray-
based methods for defining specificity like SELEX or EMSA. First,
it requires only a fraction of the time and effort of either of those
methods. Second, bound sequences are determined in a single
binding reaction, avoiding the problem of overselection that is
associated with iterative selection in SELEX experiments (Roulet
et al. 2002). Third, long genomic sequences are used rather than
short oligonucleotides, ensuring that binding sites are found
within a relevant sequence context. These advantages also apply
to microarray methods that directly detect the binding of pro-
teins to spotted DNA microarrays (Bulyk et al. 2001). Direct de-
tection avoids the need to enrich bound sequences by affinity
purification, but there are likely to be greater challenges in ob-
taining adequate sensitivity in direct detection.
PWMs have also been defined using ChIP-chip data, but if
the goal is to define intrinsic binding specificities, DIP-chip has
substantial advantages. First, because of the confounding effects
of other proteins binding cooperatively or in competition with
the protein of interest, the sequences enriched in a ChIP-chip
experiment are not a simple function of binding specificity. Sec-
ond, in a DIP-chip experiment, the protein concentration can be
adjusted easily to ensure that a sufficiently large number of se-
quences are significantly enriched. Without the ability to adjust
protein concentration, the number of DNA sequences sampled
by the motif-finding software may be too small for the binding-
site description to be accurate. Concentrations can be varied in
vivo, but not easily and not always reproducibly. Third, DIP-chip
uses no chemical cross-linking step, avoiding the potential for
protein-specific or DNA sequence-based biases in cross-linking
efficiency that are inherent in ChIP-chip experiments. It might
be necessary to use cross-linking in a DIP-chip experiment as
well, if an exceptionally weak binding protein were being stud-
ied, but this should not generally be necessary.
In this study, we have focused on the use of DIP-chip to
define DNA-binding specificities and have described computa-
tional procedures for defining and evaluating position weight
matrices obtained in this way. However, the experimental pro-
tocol for DIP-chip can also be used for a rather different purpose,
which is comparing the sites of binding in vitro with the sites of
binding in vivo, as defined by ChIP-chip. As expected, we find a
significant overlap among the microarray features that are en-
riched by binding of the Leu3p DNA binding domain in vitro and
in vivo (P ≈ 10130 for features enriched at a 1% false discovery
rate; X. Liu, N.D. Clarke, and J.D. Lieb, in prep.). Comparisons of
Figure 3. Four representations of Leu3p-binding specificity, derived
from the indicated in vitro binding experiments.
Figure 4. A comparison of the ability of DNA-binding motifs derived
from different in vitro experiments to explain in vivo binding patterns.
(A) Receiver Operator Characteristic (ROC) curve for quantitating how
well a DIP-chip derived PWM can predict the results of a ChIP-chip ex-
periment. The best PWM defined by the 4-nM DIP-chip data was used to
calculate this plot (Methods; Fig. 2). Identical analyses were performed
on PWMs derived from SELEX, EMSA, and all DIP-chip PWMs. (B) Areas
under the ROC curve for PWMs evaluated against the ChIP data. The 95%
confidence interval for the EMSA Kd ROC AUC value was estimated
by bootstrap resampling of the occupancy scores and enrichment values
for the 22 ChIP-enriched features. For the DIP-chip defined PWMs, the
PWM that scored best when evaluated against the DIP data itself is shown
as a filled circle. Other PWMs that are within the confidence interval of
the best when evaluated against the DIP data are shown as open circles.




DIP-chip and ChIP-chip experiments will be useful in determin-
ing how much of the specificity of in vivo interactions depends
on chromatin and other nuclear factors, and how much is inher-
ent to the protein and DNA itself. We also envision DIP-chip
experiments being performed with additional proteins in the re-
action mixture to observe how they affect DNA-binding specific-
ity. The ultimate goal of this line of experimentation would be to
reconstruct in vitro the precise binding distribution observed
in vivo. We conclude that DIP-chip is a powerful adjunct to
ChIP-chip experiments, and as described here, is an efficient




Plasmid pMAL-c2-Leu3(1–147) (Liu and Clarke 2002) was used as
follows to express an MBP-tagged Leu3p DNA-binding domain
(MBP-leu3pDB) in Escherichia coli BL21 cells. Bacteria were grown
in rich medium (yeast extract 5 g/L, tryptone 10 g/L, NaCl 5 g/L,
and glucose 2 g/L supplemented with 100 µg/mL of ampicillin)
with shaking at 37°C to an A600 of 0.5 and induced by addition
of IPTG (0.3 mM). After 2 h, cells were collected and frozen in
column buffer (20 mM TriṡCl at pH 7.4, 200 mM NaCl, 1 mM
EDTA, and 1 mM DTT) overnight at 20°C. Cells were thawed in
a cold water bath and disrupted by sonication. Cell debris was
removed by centrifugation at 9000g, and the supernatant was
passed through an amylose resin column (NEB). MBP-Leu3pDB
was eluted with column buffer + 10 mM Maltose. Maltose was
removed from the eluted protein by successive concentration
and resuspension using a 30-kD molecular weight cutoff spin
column (Microcon-30, Amicon). Protein purity was determined
by SDS-PAGE, and concentration was determined by the Bio-Rad
protein assay (Bio-Rad).
Genomic DNA purification
Strain BY4720-leu3neo carrying pRS416-TEF1-MBPLeu3pDB was
cultured in YPD medium (yeast extract 10 g/L, peptone 20 g/L,
supplemented with 2% glucose) to an A600 of 2. Collected cells
were suspended in 200 µL solution A (2% Triton X-100, 1% SDS,
0.1 M NaCl, 10 mM Tris at pH 8, and 1 mM EDTA), 200 µL
phenol/chloroform and 0.3 g acid-washed glass beads (Sigma
G8772), and vortexed for 5 min. We added 200 µL TE (pH 8) to
the extract and centrifuged for 5 min to collect the upper aque-
ous layer. The supernatant was then sonicated to fragment DNA
to an average size of ∼0.6 kb. DNA was purified by phenol and
phenol/chloroform extractions and ethanol precipitation. Ge-
nomic DNA was resuspended in TE (pH 8) + 30 µg/mL RNaseA at
37°C for 15 min. It was then re-extracted with phenol/chloro-
form, ethanol precipitated, and resuspended in 10 mM TriṡCl
(pH 8). DNA concentration and purity were determined by ab-
sorption spectroscopy.
DNA immunoprecipitation (DIP) reactions
Purified MBP-leu3pDB and genomic DNA were mixed in 100 µL
of binding/washing buffer (10 µM ZnSO4, 2 mM MgCl2, 2 mM
TriṡCl at pH 7.4, 100 mM KCl, and 10% glycerol) and incubated
at 30°C for 30 min. The final protein concentration was either
4 or 40 nM, and the DNA concentration was 2 µg/mL (equal to
0.3 pM genome). The solution was then mixed with 10 µL buffer-
washed amylose resin, incubated at 30°C for 15 min with mixing
by repeated pipetting, and then washed with binding/washing
buffer four times. Protein–DNA complexes were eluted with col-
umn buffer supplemented with 10 mM maltose. The 4-nM MBP-
Leu3pDB DIP experiment was repeated independently three
times (independent mixtures of protein and DNA, and indepen-
dent DNA microarrays), while the 40- nM DIP experiment was
repeated independently four times. Control experiments using
the MBP protein itself were performed six times.
Chromatin immunoprecipitation (ChIP) reactions
Yeast strain BY4720-leu3neo, carrying a plasmid that expresses
MBP-leu3pDB (pRS416-TEF1-MBPLeu3pDB) was used for the
ChIP-chip experiments. The strain was constructed, in this work,
by replacement of the LEU3 coding region by the NEO gene
in Saccharomyces cerevisiae strain BY4720 (MATalpha lys20
trp163 ura30) (Brachmann et al. 1998). pRS416-TEF1-
MBPLeu3pDB was constructed by insertion of the MBPLeu3p-DB
coding sequence into plasmid pRS416-TEF1 (URA3+ ampr),
which contains the TDH3 promoter and CYC1 terminator (Sew-
ing et al. 1994). Yeast were grown in uracil dropout medium
(YNB-AA (Sigma) 6.7 g/L, 0.77 g/L Ura DO Supp. (Clonetech), and
2% glucose supplemented with G418 at 200 mg/L) with shaking
at 30°C to an A600 of ∼1.0, at which point formaldehyde was
added to a final concentration of 1%. The culture was maintain-
ed with shaking at 30°C for 15 min. Cells were collected and
lysed by Beadbeater with glass beads (Sigma G8772) in bead-
beater lysis buffer (50 mM Hepes-KOH at pH 7.5, 10 mM MgCl2,
150 mM KCl, 0.1 mM EDTA, 10% glycerol, 0.1% NP-40, 1 mM
DTT, 1mM sodium metabisulfate and protease inhibitors). The
supernatant was then sonicated to fragment DNA to an average
size of ∼0.5 kb.
We carried out ChIP assays as described (Lieb et al. 2001)
with anti-MBP (Abcam ab65) and protein G agarose (SIGMA
83219), except that after the ChIP, we washed protein G-agarose
beads twice with lysis buffer (0.1% SDS, 0.5% Triton X-100, 20
mM TriṡCl at pH 8.0, 150 mM NaCl, and protease inhibitors),
twice with lysis buffer + 2mM EDTA (pH 8.0), once with LiCl
Buffer (0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA at
pH 8.0 and 10 mM TriṡCl at pH 8.0) and twice with TE. Both the
input protein–DNA mixture and the IP-enriched DNA were pu-
rified by QIAquick PCR purification kit (QIAGEN) after reversing
cross-links at 65°C for 6 h. ChIP of the MBP-Leu3pDB was per-
formed in replicate five times. A control experiment using an
MBP-tagged fragment of Leu3p incapable of DNA binding (dele-
tion of residues 13–601) was performed independently seven
times.
DNA amplification, labeling, and microarray hybridization
IP-enriched DNA and input DNA (used as reference) was ampli-
fied as described, with a random-primed, PCR-based method
(Lieb et al. 2001). Amplified DNA was labeled by either Cy5
or Cy3 monofunctional ester. In half of the experiments, IP-
enriched DNA was labeled with Cy5 and reference DNA by Cy3,
while in the other half, the fluorophores were swapped. Cy5- and
Cy3-labeled DNA samples were mixed and hybridized to a ge-
nomic DNA microarray. Detailed protocols are available at
http://www.bio.unc.edu/faculty/lieb/labpages/Protocols.shtml.
Array images were acquired with a GenePix 4000B scanner
(Axon Instruments), and data extracted using GenePix Pro 4.0
software. These data were uploaded to the University of North
Carolina (UNC) Microarray Database (https://genome.unc.edu/),
from which were retrieved the normalized median intensity val-
ues for each channel and the standard deviation of the back-
ground intensity for each channel.




The intensities of each channel at each spot were analyzed
using a single-array error model (Ren et al. 2000; Roberts et al.
2000) with minor modifications. The significance attached to




12 + 22 + f2a22 + a12
where a1 and a2 are the intensities measured in the two channels
at that spot, 1 and 2 are estimated errors for the two intensities
due to background subtraction, and f and s are terms that are
adjusted to achieve the desired distribution of X values. f is ad-
justed so that the distribution of X values is close to normal for
an experiment in which no significant enrichment is expected at
all. This is the case, for example, with a control experiment in
which the protein used has no DNA-binding activity. Even in a
real experiment, if relatively few features are bound, then the
distribution of X values is expected to be close to normal. s is
adjusted so that the variance of X values is equal to 1; this allows
comparisons among replicate experiments.
The X statistic, calculated for each spot on an array, is used
to weight measurements obtained from replicate experiments.
For each replicate, the enrichment, Ri, of feature i is defined as









where wi is the weight for the enrichment of spot i from a par-
ticular array and the summations are over all arrays. The weights
are calculated from the significance statistic Xi by first defining
the uncertainty (i) in the enrichment (Ri) as i = Ri /Xi. The
weight attached to each value of Ri is then wi = 1/i
2. For the
results reported here, the calculation of the weighted mean, as








where the term (wiRi)norm means that the values of wiRi are first
normalized so that the standard deviation of the values was the
same in each array. This was done because of overall differences
in the intensities of hybridization from replicate to replicate, but
in practice, this normalization had only a small effect on the
identification of enriched features.
In order to now estimate the p-value for enrichment, we first
estimate the standard deviation, m, in the mean enrichment for
each spot by propagating the uncertainty in the enrichment of





The more the mean ratio of intensities exceeds this estimate
of the standard deviation, the more likely it is that there is true
enrichment. Thus,
P-value = 1 − erf |Ri|
m

where the erf() function is the standard cumulative distribution
function for the area under a normal curve area. The error model
was implemented in R (version 1.8.0).
Sequence manipulation and computational analysis
The yeast genome sequence and its annotations were down-
loaded from the Saccharomyces Genome Database http://www.
yeastgenome.org. The sequences of microarray features, and their
genomic coordinates, were derived by J. Granek (Johns Hopkins)
based on the primer sequences used to amplify the array features.
Primer sequences are available from the UNC Microarray Data-
base https://genome.unc.edu. Genomic features enriched in con-
trol experiments (P < 0.001) and mitochondrial features were not
used in the analysis.
Occupancy scores of microarray features were calculated as
described for gene regulatory regions (Liu and Clarke 2002), but
with modifications. Briefly, an occupancy score for a feature is
based on the probability of binding to each subsequence that is
either within the feature, or within 1000 bp on either side of the
feature. The probability of binding to a particular subsequence,




where [P] is the free protein concentration and Kd,i is the equi-
librium dissociation constant of site i. Since the free concentra-
tion of protein in vivo is unknown, we used a value for [P] equal
to the estimated Kd for the optimal binding site (Kd,optimal),
which gives a binding probability of 0.5 for that site. The optimal
binding site is defined as the variant of the binding site in which
the most favored base is found at each position. Dividing both
the numerator and denominator of the previous equation by
Kd,optimal, and remembering that [P] is defined as being equal to




Equilibrium constants are estimated from a position weight
matrix. The simplest such calculation can be performed when the
elements of the PWM represent the contribution of each base to
the free energy of binding. PWMs of this type can be obtained
from a fit to experimental data for the binding affinity of a large
number of binding sites (Liu and Clarke 2002). In this case, the
binding free energy, Gi, can be estimated from summation of
the relevant PWM terms, and Kd,i = exp(Gi,/RT). Fortunately,
similar PWMs can be derived using the base frequency at each
position in a set of known or suspected binding sites, which is a
more common source of information on DNA-binding specific-
ity. The ratio of the observed frequency of a base at a particular
position to the expected frequency (base composition) can be
thought of as an equilibrium constant, which can then be con-
verted to a PWM element representing the contribution to the
free energy of binding (Stormo and Fields 1998).
Having calculated the probability of binding, pi, to all pos-
sible sites, the occupancy score, S, for the entire feature is de-
fined as




where the summation is over all possible sites, i, within the fea-
ture or within 1000 bp of the ends. wi is the weight assigned
to site i. Sites within the feature are given a weight of 1, while




declining as a linear function of distance from the feature bound-
ary. The calculation of occupancy scores, and the assessment of
the correlation between predicted occupancy and observed en-
richment in the ChIP or DIP experiments, were performed using
a computer program called GOMER (Generalizable Objective
Model of Expression Regulation) (J. Granek and N.D. Clarke, in
prep.). GOMER is available upon request from N.D. Clarke at
nclarke@jhmi.edu.
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